open access

Vol 80, No 12 (2022)
Short communication
Published online: 2022-12-23
Get Citation

How to decrease the cost of pacemaker infection treatment by adopting seemingly costly innovation? A budget impact analysis of a leadless pacemaker implantation

Paweł Syska1, Michał M Farkowski1, Monika Raulinajtys-Grzybek2, Aneta Lis3, Mariusz Pytkowski1
DOI: 10.33963/KP.a2022.0284
·
Pubmed: 36573599
·
Kardiol Pol 2022;80(12):1260-1262.
Affiliations
  1. 2nd Department of Heart Arrhythmia, National Institute of Cardiology, Warszawa, Poland
  2. Department of Management Accounting, Warsaw School of Economics, Warszawa, Poland
  3. Hospital-based Health Technology Assessment Team, National Institute of Cardiology, Warszawa, Poland

open access

Vol 80, No 12 (2022)
Short communication
Published online: 2022-12-23

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

How to decrease the cost of pacemaker infection treatment by adopting seemingly costly innovation? A budget impact analysis of a leadless pacemaker implantation

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 12 (2022)

Article type

Short communication

Pages

1260-1262

Published online

2022-12-23

Page views

539

Article views/downloads

77

DOI

10.33963/KP.a2022.0284

Pubmed

36573599

Bibliographic record

Kardiol Pol 2022;80(12):1260-1262.

Authors

Paweł Syska
Michał M Farkowski
Monika Raulinajtys-Grzybek
Aneta Lis
Mariusz Pytkowski

References (15)
  1. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020; 22: 515–549.
  2. Romanek J, Farkowski M, Bukowski H, et al. The cost of CIED infectious complications treatment in Poland from the perspective of Polish hospitals. Kardiol Pol. 2022; 80(9): 919–925.
  3. Clémenty N, Carion PL, Léotoing Lde, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study. Europace. 2018; 20(12): 1974–1980.
  4. Kaczmarek K, Strzelecki A, Ptaszyński P, et al. The safety, efficacy, and cost-effectiveness of gentamycin-collagen sponge in multicomponent prevention strategy of cardiac implantable electronic device infections - a single-center experience. Kardiol Pol. 2021; 79(10): 1079–1085.
  5. Kay G, Eby EL, Brown B, et al. Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection. J Med Econ. 2018; 21(3): 294–300.
  6. El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019; 30(4): 569–574.
  7. El-Chami MF, Soejima K, Piccini JP, et al. Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol. 2019; 42(8): 1105–1110.
  8. Kempa M, Mitkowski P, Kowalski O, et al. Expert opinion of a Working Group on Leadless Pacing appointed by the National Consultant in Cardiology and the Board of the Heart Rhythm Section of the Polish Cardiac Society. Kardiol Pol. 2021; 79(5): 604–608.
  9. Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health. 2014; 17(1): 5–14.
  10. Ahmed FZ, Fullwood C, Zaman M, et al. Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study. PLoS One. 2019; 14(1): e0206611.
  11. Gitenay E, Molin F, Blais S, et al. Cardiac implantable electronic device infection: detailed analysis of cost implications. Can J Cardiol. 2018; 34(8): 1026–1032.
  12. Grabowski M, Michalak M, Gawałko M, et al. Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis. Cardiol J. 2020; 27(1): 47–53.
  13. Gąsior M, Gierlotka M, Tycińska A, et al. Effects of the coronavirus disease 2019 pandemic on the number of hospitalizations for myocardial infarction: regional differences. Population analysis of 7 million people. Kardiol Pol. 2020; 78(10): 1039–1042.
  14. Myrda K, Błachut A, Buchta P, et al. Clinical characteristics of patients with atrial fibrillation or atrial flutter hospitalized during the COVID-19 pandemic: a population analysis of nearly 5 million people. Pol Arch Intern Med. 2021; 131(6): 574–577.
  15. Farkowski MM, Lach K, Pietrzyk M, et al. The Need to Implement Health Technology Assessment in Polish Hospitals-A Survey of 50 Hospital Managers. Int J Environ Res Public Health. 2022; 19(14).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl